Old and new anti-obesity drugs

被引：0

作者：

Dodangeh, Salimeh ^{[1
]}

Hasani-Ranjbar, Shirin ^{[2
]}

机构：

[1] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran

[2] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Obes & Eating Habits Res Ctr, Tehran, Iran

来源：

JOURNAL OF DIABETES AND METABOLIC DISORDERS | 2024年 / 24卷 / 01期

关键词：

Obesity; Overweight; Anti-obesity medication; Weight loss medication; GLUCAGON-LIKE PEPTIDE-1; GLP-1 RECEPTOR AGONIST; WEIGHT-LOSS; CLINICAL ENDOCRINOLOGISTS; APPETITE SUPPRESSION; AMERICAN ASSOCIATION; EXTENDED-RELEASE; GENE-EXPRESSION; OBESE-PATIENTS; DOUBLE-BLIND;

D O I：

10.1007/s40200-024-01512-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Obesity is a pandemic problem that correlates with a cluster of metabolic factors leading to poor cardiovascular outcomes, morbidity, and an increased risk of overall mortality. It is necessary to approach obesity with a comprehensive treatment plan, which may involve lifestyle modifications (diet, exercise, and behavioral therapy) and pharmacological interventions. This article provides an overview of the mechanisms of action, efficacy, and safety of available long-term anti-obesity drugs and introduces other potential agents under investigation.

引用

页数：13

共 50 条

[41] The obesity pipeline: current strategies in the development of anti-obesity drugs
Cooke, Dunstan
Bloom, Steve
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (11) : 919 - 931
[42] New anti-obesity genes identified
不详
DIABETES OBESITY & METABOLISM, 1999, 1 (03): : 182 - 182
[43] Cardiovascular Effects of Current and Future Anti-Obesity Drugs
Comerma-Steffensen, Simon
Grann, Martin
Andersen, Charlotte U.
Rungby, Jorgen
Simonsen, Ulf
CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (03) : 493 - 504
[44] Memantine: A new anti-obesity drug
Holt, RIG
DIABETES OBESITY & METABOLISM, 2005, 7 (05): : 620 - 620
[45] A risk-benefit assessment of anti-obesity drugs
Kolanowski, J
DRUG SAFETY, 1999, 20 (02) : 119 - 131
[46] Comprehensive Review of Current and Upcoming Anti-Obesity Drugs
Son, Jang Won
Kim, Sungrae
DIABETES & METABOLISM JOURNAL, 2020, 44 (06) : 802 - 818
[47] Regulation of food intake and the development of anti-obesity drugs
Chen, Yue
DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (02): : 62 - 73
[48] EFFECT OF ANTI-OBESITY DRUGS ON LIPASE ACTIVITY INVITRO
HOLMES, JH
SAPEIKA, N
ZWARENSTEIN, H
RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1975, 10 (04): : 739 - 742
[49] A Risk-Benefit Assessment of Anti-Obesity Drugs
Jaroslaw Kolanowski
Drug Safety, 1999, 20 : 119 - 131
[50] Characteristics of diabetic patients starting anti-obesity drugs
Willemen, M. J. C.
Mantel-Teeuwisse, A. K.
Straus, M. J. M.
Leufkens, H. G. M.
Egberts, A. C. G.
DRUG SAFETY, 2007, 30 (10) : 968 - 968

← 1 2 3 4 5 →